Altria has sent a letter to the U.S. Food and Drug Administration (FDA) requesting that the agency push back the May 12 authorization deadline by eight weeks due to the coronavirus outbreak. In order to Read More
Altria has sent a letter to the U.S. Food and Drug Administration (FDA) requesting that the agency push back the May 12 authorization deadline by eight weeks due to the coronavirus outbreak. In order to Read More
